Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy

Inclusion Criteria: * Ambulatory with radiating low back and leg pain for greater than 6 months prior to surgery with clinical diagnosis of lumbar protruding disc. * Consent and compliance with all aspects of the study protocol, methods, providing data during follow-up contact. Exclusion Criteria: * Severe hypertension systolic blood pressure (greater than or equal to 200 mm -Hg or diastolic blood pressure greater than or equal to 182 mm Hg) * BMI greater than 45 kg/m2 * Subject has had major surgery at the index level * Is an active smoker or stopped smoking in the last 6 months * Any pain that could interfere with the assessment of index level pain (e.g. pain in any other part of the spine) * Active rheumatoid arthritis * Active, local or systemic malignancy such as lung cancer or leukemia * History of vascular disease or sickle cell anemia * Use of the following medications: No significant anticoagulant therapy (e.g. Heparin or Lovenox) during the study (treatment such as Aspirin and Plavix are allowed) * No systemic treatments that may interfere with safety or efficacy assessments during the study * No immunosuppressants * No use of corticosteroids * Subject is pregnant or plans to become pregnant within 24 months of treatment * Subject does not provide full consent * Personal injury, workman's compensation or other legally-related treatment patients.